Galderma Patents Oral Acne Treatment
Published April 1, 2014
US Patent No. 8,658,189 B2; Galderma has been awarded a patent for an oral method of treating acne in a human. It entails administering systemically a tetracycline compound in an amount that is effective to treat acne but has substantially no antibiotic activity, without administering a bisphosphonate compound.
blog comments powered by Disqus